Target ALS is an accelerator. Based in New York City, United States. Known portfolio companies include NRG Therapeutics, AcuraStem, Mabylon and NeuroDex, 4 companies in all.
Is Target ALS a fit for your startup?
Paste your website. AI checks the fit and scores every other investor too.
Investment focus
- Sector
- Healthcare
- Focus
- BiomarkersBiotechClinical TrialsDrug DiscoveryGenomicsGrantmakerNonprofitResearch ConsortiaTherapeutics
Who to pitch at Target ALS
Target ALS portfolio companies (4)
- NRG Therapeutics
- AcuraStem
- Mabylon
- NeuroDex
Co-investors
Funds that share portfolio companies with Target ALS.
Similar funds
Showing 20 of 100
About Target ALS
The firm's listing covers sector Healthcare, and focus areas Biomarkers, Biotech, Clinical Trials and Drug Discovery.
The contact to approach at Target ALS is Dan Doctoroff (Founder and Chairman).
Across the known portfolio, 8 co-investors appear alongside Target ALS, including Criteria Bio Ventures, The ALS Association and Omega Funds.
Frequently asked questions
What is Target ALS?
Target ALS is an accelerator based in New York City, United States, with a known portfolio of 4 companies. The portfolio comes from public investment records rather than from the firm, so deals that never surfaced publicly are not in it.
What does Target ALS invest in?
Listed sectors include Healthcare; listed focus areas include Biomarkers, Biotech, Clinical Trials and Drug Discovery. Those tags come from the portfolio attached to the firm, so they describe what has been backed rather than a stated mandate for what comes next.
Who should I pitch at Target ALS?
One person at Target ALS is on file, listed as a contact for the firm, with their own profile page.
How do I contact Target ALS?
Any email address on file for the firm is masked on this page and readable inside RaiseHunt after you create an account. The one person attached to the firm has their own page, which shows whether an address is on file for them.
Skip the browsing. Let AI find your ideal investors in one minute.
Paste your startup website and AI picks your best-fit investors out of 135,000+ profiles.
Data: RaiseHunt investor dataset · Snapshot 5 September 2026 · How this data is built · Report a correction or request removal